2nd Quarter - Report — NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION (2009)

Firm

NATIONAL PATIENT ADVOCATE FOUNDATION

Client

NATIONAL PATIENT ADVOCATE FOUNDATION

Income

—

Expenses

$53,218

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Labor HHS Appropriations: appropriations levels for NIH, NCI, CDC, and AHRQ Labor HHS Appropriations: appropriations for Patient Advocate Foundation VCUP and MS Delta Health Alliance Agriculture Appropriations: appropriations level for FDA

Lobbyist	Covered position, as disclosed
NANCY DAVENPORT-ENNIS	—
GRAYSON FOWLER	—
AMY WOTRING	—

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Assuring and Improving Cancer Treatment Education and Cancer Symptom Management Act, Access to Cancer Clinical Trials Act, Cancer Drug Parity Act of 2009, Informed Consumer Choices Act, EARLY Act, Community Choice Act of 2009, comparative effectiveness research, SCHIP, health IT, biomedical research, wellness & prevention, insurance market reforms, medical debt, Medical Bankruptcy Fairness Act, COBRA, follow-on biologics, physician reimbursement

Lobbyist	Covered position, as disclosed
NANCY DAVENPORT-ENNIS	—
GRAYSON FOWLER	—
AMY WOTRING	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Medicaid spending, Medicare reimbursement, SCHIP, Medicare IVIG Access Act of 2009, Medicare waiting period, Medicare buy-in, Medicare Financial Stability for Beneficiaries Act of 2009, health care reform

Lobbyist	Covered position, as disclosed
NANCY DAVENPORT-ENNIS	—
GRAYSON FOWLER	—
AMY WOTRING	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.